Arisaph Pharmaceuticals Garners $10,000,000 New Round

  • Feed Type
  • Date
    11/1/2013
  • Company Name
    Arisaph Pharmaceuticals
  • Mailing Address
    100 High Street Boston, MA 02110
  • Company Description
    Arisaph Pharmaceuticals, Inc. is an emerging drug discovery and design biopharmaceutical company located in Boston, Massachusetts, an internationally recognized center of biotechnology. The company utilizes proprietary drug discovery platforms to develop differentiated drugs that are highly potent and act on select targets for the treatment of a variety of diseases.
  • Website
    http://www.arisaph.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $10,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.